Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFMW) Assets Average (2016 - 2025)

Historic Assets Average for Sunshine Biopharma (SBFMW) over the last 13 years, with Q3 2025 value amounting to $31.7 million.

  • Sunshine Biopharma's Assets Average rose 689.86% to $31.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.7 million, marking a year-over-year increase of 689.86%. This contributed to the annual value of $29.0 million for FY2024, which is 232.64% up from last year.
  • According to the latest figures from Q3 2025, Sunshine Biopharma's Assets Average is $31.7 million, which was up 689.86% from $30.6 million recorded in Q2 2025.
  • Over the past 5 years, Sunshine Biopharma's Assets Average peaked at $41.4 million during Q3 2022, and registered a low of $1.5 million during Q1 2021.
  • In the last 5 years, Sunshine Biopharma's Assets Average had a median value of $28.1 million in 2023 and averaged $23.3 million.
  • As far as peak fluctuations go, Sunshine Biopharma's Assets Average soared by 181839.86% in 2022, and later tumbled by 3233.95% in 2023.
  • Over the past 5 years, Sunshine Biopharma's Assets Average (Quarter) stood at $2.4 million in 2021, then soared by 1390.14% to $35.1 million in 2022, then fell by 21.55% to $27.5 million in 2023, then grew by 10.22% to $30.3 million in 2024, then rose by 4.68% to $31.7 million in 2025.
  • Its last three reported values are $31.7 million in Q3 2025, $30.6 million for Q2 2025, and $29.9 million during Q1 2025.